Type IV hyperlipoproteinaemia.
D002648:Child; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004035:Diet Therapy; D004040:Dietary Carbohydrates; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D007328:Insulin / Q000378:metabolism; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D009640:Norethindrone / Q000627:therapeutic use; D010195:Pancreatitis / Q000150:complications; D010641:Phenotype; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D014527:Uric Acid / Q000097:blood; D014652:Vascular Diseases / Q000150:complications; D014973:Xanthomatosis / Q000150:complications
D002914:Chylomicrons; D004040:Dietary Carbohydrates; D007328:Insulin; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D002994:Clofibrate; D009640:Norethindrone